BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23211527)

  • 1. SCF-mediated degradation of p100 (NF-κB2): mechanisms and relevance in multiple myeloma.
    Busino L; Millman SE; Pagano M
    Sci Signal; 2012 Dec; 5(253):pt14. PubMed ID: 23211527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma.
    Busino L; Millman SE; Scotto L; Kyratsous CA; Basrur V; O'Connor O; Hoffmann A; Elenitoba-Johnson KS; Pagano M
    Nat Cell Biol; 2012 Mar; 14(4):375-85. PubMed ID: 22388891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway.
    Arabi A; Ullah K; Branca RM; Johansson J; Bandarra D; Haneklaus M; Fu J; Ariës I; Nilsson P; Den Boer ML; Pokrovskaja K; Grandér D; Xiao G; Rocha S; Lehtiö J; Sangfelt O
    Nat Commun; 2012; 3():976. PubMed ID: 22864569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.
    Zhang Z; Wang Y; Li C; Shi Z; Hao Q; Wang W; Song X; Zhao Y; Jiao S; Zhou Z
    J Biol Chem; 2015 Aug; 290(32):19558-68. PubMed ID: 26112410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SCF(Fbw7) modulates the NFkB signaling pathway by targeting NFkB2 for ubiquitination and destruction.
    Fukushima H; Matsumoto A; Inuzuka H; Zhai B; Lau AW; Wan L; Gao D; Shaik S; Yuan M; Gygi SP; Jimi E; Asara JM; Nakayama K; Nakayama KI; Wei W
    Cell Rep; 2012 May; 1(5):434-43. PubMed ID: 22708077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism by which thiazolidinediones facilitate the proteasomal degradation of cyclin D1 in cancer cells.
    Wei S; Yang HC; Chuang HC; Yang J; Kulp SK; Lu PJ; Lai MD; Chen CS
    J Biol Chem; 2008 Sep; 283(39):26759-70. PubMed ID: 18650423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FBW7 regulates endothelial functions by targeting KLF2 for ubiquitination and degradation.
    Wang R; Wang Y; Liu N; Ren C; Jiang C; Zhang K; Yu S; Chen Y; Tang H; Deng Q; Fu C; Wang Y; Li R; Liu M; Pan W; Wang P
    Cell Res; 2013 Jun; 23(6):803-19. PubMed ID: 23507969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The hormone-bound vitamin D receptor enhances the FBW7-dependent turnover of NF-κB subunits.
    Fekrmandi F; Wang TT; White JH
    Sci Rep; 2015 Aug; 5():13002. PubMed ID: 26269414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of GATA-binding protein 2 levels via ubiquitin-dependent degradation by Fbw7: involvement of cyclin B-cyclin-dependent kinase 1-mediated phosphorylation of THR176 in GATA-binding protein 2.
    Nakajima T; Kitagawa K; Ohhata T; Sakai S; Uchida C; Shibata K; Minegishi N; Yumimoto K; Nakayama KI; Masumoto K; Katou F; Niida H; Kitagawa M
    J Biol Chem; 2015 Apr; 290(16):10368-81. PubMed ID: 25670854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A colon cancer-derived mutant of Krüppel-like factor 5 (KLF5) is resistant to degradation by glycogen synthase kinase 3β (GSK3β) and the E3 ubiquitin ligase F-box and WD repeat domain-containing 7α (FBW7α).
    Bialkowska AB; Liu Y; Nandan MO; Yang VW
    J Biol Chem; 2014 Feb; 289(9):5997-6005. PubMed ID: 24398687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
    Spagnol V; Oliveira CAB; Randle SJ; Passos PMS; Correia CRSTB; Simaroli NB; Oliveira JS; Mevissen TET; Medeiros AC; Gomes MD; Komander D; Laman H; Teixeira FR
    Biochim Biophys Acta Gen Subj; 2021 Jan; 1865(1):129754. PubMed ID: 33010352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCL-3 degradation involves its polyubiquitination through a FBW7-independent pathway and its binding to the proteasome subunit PSMB1.
    Keutgens A; Zhang X; Shostak K; Robert I; Olivier S; Vanderplasschen A; Chapelle JP; Viatour P; Merville MP; Bex F; Gothot A; Chariot A
    J Biol Chem; 2010 Aug; 285(33):25831-40. PubMed ID: 20558726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
    Pérez-Benavente B; García JL; Rodríguez MS; Pineda-Lucena A; Piechaczyk M; Font de Mora J; Farràs R
    Oncogene; 2013 Apr; 32(17):2189-99. PubMed ID: 22710716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.
    Keats JJ; Fonseca R; Chesi M; Schop R; Baker A; Chng WJ; Van Wier S; Tiedemann R; Shi CX; Sebag M; Braggio E; Henry T; Zhu YX; Fogle H; Price-Troska T; Ahmann G; Mancini C; Brents LA; Kumar S; Greipp P; Dispenzieri A; Bryant B; Mulligan G; Bruhn L; Barrett M; Valdez R; Trent J; Stewart AK; Carpten J; Bergsagel PL
    Cancer Cell; 2007 Aug; 12(2):131-44. PubMed ID: 17692805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
    Kannan MB; Dodard-Friedman I; Blank V
    J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction.
    Inuzuka H; Shaik S; Onoyama I; Gao D; Tseng A; Maser RS; Zhai B; Wan L; Gutierrez A; Lau AW; Xiao Y; Christie AL; Aster J; Settleman J; Gygi SP; Kung AL; Look T; Nakayama KI; DePinho RA; Wei W
    Nature; 2011 Mar; 471(7336):104-9. PubMed ID: 21368833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBXW7 modulates cellular stress response and metastatic potential through ​HSF1 post-translational modification.
    Kourtis N; Moubarak RS; Aranda-Orgilles B; Lui K; Aydin IT; Trimarchi T; Darvishian F; Salvaggio C; Zhong J; Bhatt K; Chen EI; Celebi JT; Lazaris C; Tsirigos A; Osman I; Hernando E; Aifantis I
    Nat Cell Biol; 2015 Mar; 17(3):322-332. PubMed ID: 25720964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Kinase Assay for Measuring the Activity of the NIK-IKK1 Complex Induced via the Noncanonical NF-κB Pathway.
    Mukherjee T; Ratra Y; Banoth B; Deka A; Polley S; Basak S
    Methods Mol Biol; 2021; 2366():165-181. PubMed ID: 34236638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin ligase SCF
    Song N; Cao C; Tang Y; Bi L; Jiang Y; Zhou Y; Song X; Liu L; Ge W
    J Cell Physiol; 2018 Mar; 233(3):2366-2377. PubMed ID: 28722108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The noncanonical NF-κB pathway.
    Sun SC
    Immunol Rev; 2012 Mar; 246(1):125-40. PubMed ID: 22435551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.